“Access to Medicines in Low- and Middle-Income Countries – Is the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to blame?” (2024) Ghana Pharmaceutical Journal, 25(1), pp. 1–9. doi:10.38159/q1zweb53.